Alimanio, Cj M.

HRN: 12-82-68  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/23/2022
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
05/23/2022
05/30/2022
PO
4ml
Bid
Age With Moderate Dhn, Uti
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: